Novabay Pharmaceuticals Inc Валовая прибыль

Что обозначает Валовая прибыль в Novabay Pharmaceuticals Inc?

Валовая прибыль Novabay Pharmaceuticals Inc является 53.61%

Какое определение для Валовая прибыль?



Валовая прибыль - это разница между доходом и стоимостью проданных товаров, разделенная на доход и выраженная в процентах.

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Валовая прибыль компаний в Health Care сектор на NYSEMKT по сравнению с Novabay Pharmaceuticals Inc

Что делает Novabay Pharmaceuticals Inc?

novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across

Компании с валовая прибыль похож на Novabay Pharmaceuticals Inc